Screening examination of premature infants for retinopathy of prematurity.

  title={Screening examination of premature infants for retinopathy of prematurity.},
  author={Chairperson and Edward G. Buckley and George S. Ellis and Jane D. Kivlin and Gregg T Lueder and James B. Ruben and Gary T. Denslow and Walter M. Fierson and Dale L Phelps and James D. Reynolds and Richard A Saunders},
  volume={108 3},

Figures and Tables from this paper

Screening Examination of Premature Infants for Retinopathy of Prematurity

The attributes on which an effective program for detecting and treating ROP could be based are presented, including the timing of initial examination and subsequent reexamination intervals.

Retinopathy of Prematurity in the 1990s

  • S. Lee
  • Medicine
    Neonatal Network
  • 1999
The incidence, pathophysiology, risk factors, screening, treatment, and long-term complications of ROP in the 1990s are reported on.


Purpose: To assess the features of Retinopathy of Prematurity (ROP) in a Neonatal Intensive Care Unit during 8 years, analyzing the usefulness of the criteria in the screening protocol and the risk

Retinopathy of Prematurity: A Study of Incidence and Risk Factors in NICU of Al-Minya University Hospital in Egypt

The incidence of ROP in preterm infants in this study was 19.2%; low gestational age, sepsis, oxygen therapy and frequent blood transfusions were significant risk factors for ROP.

[Screening for retinopathy of prematurity. Our experience about limits of birth weight, post-conceptional age and other risk factors].

None of the children included with a BW > 1500 g required treatment for ROP, but several cases of ROP could be missed by using this criteria only, and SPC must be restricted in the screening program.

Treatment of non-type 1 retinopathy of prematurity in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) study.

Prevalence of Severe Visual Disability Among Preterm Children With Retinopathy of Prematurity and Association With Adherence to Best Practice Guidelines

Severe visual impairment associated with retinopathy of prematurity is preventable in most cases, according to this population-based cohort study of infants born alive in Sweden.

Characteristics of Severe Retinopathy of Prematurity in Infants with Birth Weight above 1500 Grams at a Referral Center in Turkey

Severe ROP may occur in heavier preterm infants and standardization of private NICU centers as well as establishing a national ROP protocol is necessary in Turkey.

Risk Calculator for Retinopathy of Prematurity Requiring Treatment

The temporal avascular area of the retina and MV time must be taken into account in the first examination of the newborn to predict the need for ROP treatment.

Screening program for retinopathy of prematurity in Spain.




Current Incidence of Retinopathy of Prematurity, 1989–1997

The incidence and severity of ROP have decreased significantly in the present era of surfactant therapy, and despite increased survival of extremely low BW infants, infants <28 weeks' GA or with BWs <1000 g were still at considerable risk for retinal surgical treatment for ROP.

Involution of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.

The onset of involution of acute retinopathy of prematurity correlates better with post menstrual rather than with chronological age, reminiscent of the reported similar correlation of postmenstrual age to the time of onset of prethreshold and threshold ROP.

Timing of initial screening examinations for retinopathy of prematurity.

Screening infants at 7 weeks of chronological age or 34 weeks of postconceptional age (whichever comes first) seems to reliably detect the onset of threshold ROP while reducing the number of unnecessary early examinations.

Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies.

The initial eye examination should be conducted by 31 weeks' postmenstrual age or 4 weeks' chronologic age, whichever is later, and acute phase ROP screening can be discontinued when any of the 3 signs is present, indicating that the risk of visual loss from ROP is minimal or passed.

Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.

  • W. Tasman
  • Medicine
    Archives of ophthalmology
  • 2003
Early treatment of high-risk prethreshold ROP significantly reduced unfavorable outcomes to a clinically important degree and led to modified recommendations for the use of peripheral retinal ablation in eyes with ROP.

Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group.

A reduction in ambient-light exposure does not alter the incidence of retinopathy of prematurity and the amount of light reaching the infants' eyes was reduced within 24 hours after birth by placing goggles on the infants that reduced visible- light exposure by 97 percent and ultraviolet-light Exposure by 100 percent.

Laser therapy for retinopathy of prematurity.

In the letter on laser therapy for retinopathy of prematurity (ROP), 1 the article by McNamara et al, 2 which is referenced by the Laser ROP Study Group in Table 1 of the letter, is reported to

Multicenter trial of cryotherapy for retinopathy of prematurity. 3 1/2-year outcome--structure and function. Cryotherapy for Retinopathy of Prematurity Cooperative Group.

Results support the long-term efficacy and safety of cryotherapy in the treatment of severe retinopathy of prematurity.

Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group.

The efficacy of cryotherapy is supported in reducing by approximately one half the risk of unfavorable retinal outcome from threshold ROP.